Nanotechnology-based strategies for treatment of ocular disease
Ocular diseases include various anterior and posterior segment diseases. Due to the unique anatomy and physiology of the eye, efficient ocular drug delivery is a great challenge to researchers and pharmacologists. Although there are conventional noninvasive and invasive treatments, such as eye drops...
Saved in:
Main Authors: | Yuhua Weng (Author), Juan Liu (Author), Shubin Jin (Author), Weisheng Guo (Author), Xingjie Liang (Author), Zhongbo Hu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biological drug therapy for ocular angiogenesis: Anti‐VEGF agents and novel strategies based on nanotechnology
by: María L. Formica, et al.
Published: (2021) -
Ocular drug delivery: A clue from nanotechnology
by: Claudio eBucolo, et al.
Published: (2012) -
Nanotechnology for the Treatment of Allergic Conjunctival Diseases
by: Yu-Chi Liu, et al.
Published: (2020) -
Nanotechnology-Based Diagnostic and Therapeutic Strategies for Neuroblastoma
by: Hui Yan, et al.
Published: (2022) -
Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases
by: Luis F. González, et al.
Published: (2021)